New: NCI-funded clinical trial search
Mednet Logo

When a steroid-pretreated liver biopsy is reported as minimal/near-normal in suspected immune- related hepatitis, what clinical or laboratory triggers make you treat the biopsy as falsely reassuring and change course (e.g., reassess diagnosis, repeat biopsy, or escalate beyond steroids), particularly in a cholestatic presentation?